Skip to main content

Deals

Summit Partners exits Dreampath Diagnostics to Halma

Tuesday, July 7, 2026 · first reported by PE Hub

Summit Partners exits Dreampath Diagnostics, a pathology lab tracking systems provider serving 500+ labs across 50 countries, to Halma.

Also named
Dreampath Diagnostics, Halma
Asset class
Private equity

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

More in Deals

From the same day

Got news? Send it to us →